Clinical Trial Update: Observational Study on Dose Optimization of Olverembatinib in Patients With Chronic Myeloid Leukemia in Chronic or Accelerated Phase

View source ↗

Summary

An observational study update evaluating dose optimization of olverembatinib in patients with chronic myeloid leukemia in chronic or accelerated phase. The stud…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Myeloid Leukemia

Drugs mentioned

• Olverembatinib (Olverembatinib)

Snippet

Sponsor: Qian Jiang | Conditions: Chronic Myeloid Leukemia | Status: ENROLLING_BY_INVITATION